Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoFRA:7LW +0.17%81 Debt-to-Equity is 0.26 as of Mar. 2026, which is 63% above its 10-year median of 0.16. GuruFocus rates FRA:7LW with a GF Score™ of 81/100 and a GF Value™ of €6.29. The stock has 5 warning signs investors should review. Among 1,419 Chemicals companies, KNC Laboratories Co ranks better than 60.89% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for KNC Laboratories Co's Debt-to-Equity or its related term are showing as below:
FRA:7LW'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.1 Med: 0.16 Max: 0.77
Current: 0.24
During the past 11 years, the highest Debt-to-Equity Ratio of KNC Laboratories Co was 0.77. The lowest was 0.10. And the median was 0.16.
FRA:7LW's Debt-to-Equity is ranked better than 60.89% of 1419
companies
in the Chemicals industry
Industry Median: 0.36
vs FRA:7LW: 0.24
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
KNC Laboratories Co Debt-to-Equity Related Terms
KNC Laboratories Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (FRA:7LW) has a Debt-to-Equity of 0.26 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on KNC Laboratories Co and its competitors. This is 63% above median its historical median of 0.16. Over the past decade, KNC Laboratories Co's Debt-to-Equity has ranged from 0.10 to 0.77. According to the industry distribution chart, KNC Laboratories Co ranks #555 out of 1419 companies in the Chemicals industry, placing it in the top 39.1%.
Is KNC Laboratories Co's Debt-to-Equity too high?
KNC Laboratories Co's current Debt-to-Equity of 0.26 is 63% above median its 10-year median of 0.16. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.77. The Chemicals industry median Debt-to-Equity is 0.36. KNC Laboratories Co's value of 0.26 is 27.8% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #555 out of 1419 companies in the Chemicals industry, which is above the industry midpoint. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's Debt-to-Equity compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #555 out of 1419 companies for Debt-to-Equity. This puts KNC Laboratories Co in the upper half of its industry. The industry median Debt-to-Equity is 0.36. KNC Laboratories Co's value of 0.26 is 27.8% below this benchmark. Historically, KNC Laboratories Co's own Debt-to-Equity has ranged from 0.10 to 0.77 over the past decade. While the company's 10-year median is 0.16 vs. the industry median of 0.36, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,419 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current Debt-to-Equity of 0.26 is 27.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current Debt-to-Equity is 0.26, which is 63% above median its own 10-year median of 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current Debt-to-Equity of 0.26. The stock's GF Value™ is €6.29, compared to a current price of €6.05 — trading 3.8% below its estimated fair value. The current Debt-to-Equity is 0.26, which is 63% above median its 10-year median of 0.16 and 27.8% below the Chemicals industry median of 0.36. KNC Laboratories Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current Debt-to-Equity is 0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of €6.05 is trading 3.8% below its estimated GF Value™ of €6.29.
Key valuation signals for FRA:7LW:
Debt-to-Equity: 0.26 (63% above median its 10-year median of 0.16)
GF Value™: €6.29 vs. price of €6.05 (3.8% below fair value)
Industry Position: 27.8% below the Chemicals median (#555 of 1419)
No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7LW has been successfully added to your 
